Drugs
-
?
-
Drug Safety and Availability
Information for consumers and health professionals on new drug warnings and other safety information, drug label changes, and shortages of medically necessary drug products.
-
Drug Safety Communications
- FDA Drug Safety Communication: New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)
- FDA Drug Safety Communication: Clostridium difficile-associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs)
- FDA Drug Safety Communication: Important drug interactions between Victrelis (boceprevir) and ritonavir-boosted human immunodeficiency virus (HIV) protease inhibitor drugs
-
-
Drug Recalls
- Gilead Issues A Voluntary Recall Of One Lot Of VistideĀ® (CIDOFOVIR INJECTION) Due To Presence Of Particulate Matter
- Hospira issues a Voluntary Nationwide Recall of One Lot of Lactated Ringers and 5% Dextrose Injection, USP, 1000 ML, Flexible Containers Due to Non-Sterility
- Freedom Trading Issues a Voluntary Nationwide Recall of Super Power, a Product Marketed as a Dietary Supplement to Support Male Sexual Performance, Due to Undeclared, Potentially Hazardous Active Ingredient
?
-
-